Does neo-adjuvant chemotherapy improve the negative effect of lymphovascular invasion in survival after radical cystectomy?

Diminishing the Gender-Related Disparity in Survival among Chemotherapy Pre-Treated Patients after Radical Cystectomy—A Multicenter Observational Study

(2023) Krystian Kaczmarek et al.   Journal of Clinical Medicine

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial

(2023) Stéphane Culine et al.   Cancers

Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases

(2022) Anirban P. Mitra et al.   JOURNAL OF UROLOGY

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

(2021) Richard J. Sylvester et al.   EUROPEAN UROLOGY

Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis

(2021) Wojciech Krajewski et al.   Journal of Clinical Medicine

Does neoadjuvant chemotherapy diminish the sex disparity in bladder cancer survival after radical cystectomy?

(2021) Siv Venkat et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Survival of Patients with Muscle-Invasive Urothelial Cancer of the Bladder with Residual Disease at Time of Cystectomy: A Comparative Survival Analysis of Treatment Modalities in the National Cancer Database

(2020) John L. Pfail et al.   Bladder Cancer

The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder

(2016) Romain Mathieu et al.   Nature Reviews Urology

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis

(2016) Ming Yin et al.   ONCOLOGIST

Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making

(2015) Atiqullah Aziz et al.   BJU INTERNATIONAL

Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209

(2014) H. Kitamura et al.   ANNALS OF ONCOLOGY

Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: A population-based study

(2014) David M Berman et al.   INTERNATIONAL JOURNAL OF UROLOGY

Prognostic Significance of Lymphovascular Invasion in Radical Cystectomy on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis

(2014) Hwanik Kim et al.   PLoS One

Outcome of Patients with Pathological Tumor Stage T3 Urothelial Carcinoma of the Bladder following Radical Cystectomy in a Single-Center Series with 116 Patients

(2014) Johannes Breyer et al.   UROLOGIA INTERNATIONALIS

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone

(2013) Laura S. Mertens et al.   BJU INTERNATIONAL

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks

(2013) A. Buchner et al.   EJSO

The SPARC Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer

(2013) Manuel S. Eisenberg et al.   JOURNAL OF UROLOGY

Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy

(2012) David A. Green et al.   BJU INTERNATIONAL

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

(2011)   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy

(2011) Guru Sonpavde et al.   JOURNAL OF UROLOGY

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial

(2010) Christian Bolenz et al.   BJU INTERNATIONAL

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy

(2010) Guru Sonpavde et al.   BJU INTERNATIONAL

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

(2010) Shahrokh F. Shariat et al.   BJU INTERNATIONAL

Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience

(2010) Faysal A. Yafi et al.   BJU INTERNATIONAL

Lymphovascular Invasion and the Presence of More Than Three Tumors Are Associated With Poor Outcomes of Muscle-invasive Bladder Cancer After Bladder-conserving Therapies

(2010) Minguang Zhang et al.   UROLOGY

Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed

(2009) Murugesan Manoharan et al.   BJU INTERNATIONAL

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

(2007) Shahrokh F. Shariat et al.   CANCER